Meera Mohan, MD

Articles by Meera Mohan, MD

Saad Z. Usmani, MD, MBA, FACPVideo Insights | January 17, 2024
The panelists highlight key data presented at ASCO 2023.
Saad Z. Usmani, MD, MBA, FACPVideo Insights | January 17, 2024
Toxicities such as cytokine release syndrome as they relate to BCMA bispecific antibodies for myeloma are discussed.
Saad Z. Usmani, MD, MBA, FACPVideo Insights | January 17, 2024
The panel discusses the new and emerging bispecific antibody treatment options for multiple myeloma.
Saad Z. Usmani, MD, MBA, FACPVideo Insights | January 17, 2024
The panel discusses data on the BCMA CAR-T construct PHE885 and the manufacturing needs that persist.
Saad Z. Usmani, MD, MBA, FACPVideo Insights | March 15, 2024
The panel discusses the real-world data and first-hand experience with the two FDA-approved CAR T-cell therapies for MM.
Saad Z. Usmani, MD, MBA, FACPVideo Insights | January 17, 2024
The panelists discuss their experience with CAR-T access challenges in the real-world clinical setting.
Saad Z. Usmani, MD, MBA, FACPVideo Insights | January 17, 2024
The panel discusses the FDA-approved BCMA-directed CAR-T options for multiple myeloma.
Saad Z. Usmani, MD, MBA, FACPVideo Insights | January 17, 2024
The panel discusses maintenance therapy options for early-relapsed multiple myeloma.
Saad Z. Usmani, MD, MBA, FACPVideo Insights | January 17, 2024
The panel considers triplet versus quadruplet therapy for myeloma induction.
Chadi Nabhan, MD, MBA, FACPMyeloma | September 5, 2023
Dr. Mohan discusses her 2023 ASCO Annual Meeting presentation with Chadi Nabhan, MD, MBA, FACP.